Hendrik W Van Deventer

UNCCH, School of Medicine, Medicine

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

Hendrik W Van Deventer

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Medicine
  
  

Help us refine your profile

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2012

  Tyler W. Buckner; Cherie Dunphy; Yuri D. Fedoriw; Hendrik W. Van Deventer; Matthew C. Foster; Kristy L. Richards; Steven I. Park

  Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections

  Clinical Lymphoma, Myeloma and Leukemia. 2012;12(6):455-458.
  0

• 2.

  2012

  Amber M. Bradley; Allison M. Deal; Larry W. Buie; Hendrik Van Deventer

  Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor

  Pharmacotherapy. 2012;32(12):1070-1077.
  1

• 3.

  2012

  Matthew C. Foster; Chirag Amin; Peter M. Voorhees; Hendrik W. Van Deventer; Kristy L. Richards; Anastasia Ivanova; Jennifer Whitman; Wingkeung Michael Chiu; Nathan D. Barr; Thomas Shea

  A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia

  Leukemia and Lymphoma. 2012;53(7):1331-1337.
  1

• 4.

  2010

  Hendrik W. Van Deventer; Joseph E. Burgents; Qing Ping Wu; Rita-Marie T. Woodford; W. June Brickey; Irving C. Allen; Erin McElvania-Tekippe; Jonathan S. Serody; Jenny P.-Y. Ting

  The inflammasome component Nlrp3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells

  Cancer Research. 2010;70(24):10161-10169.
  11

• 5.

  2008

  Brian P. O'Connor; So-Young Eun; Zhengmao Ye; Alla L. Zozulya; John D. Lich; Chris B. Moore; Heather A. Iocca; Kelly E. Roney; Eda K. Holl; Ping Wu Quing; et al.

  Semaphorin 6D regulates the late phase of CD4⁺ T cell primary immune responses

  Proceedings of the National Academy of Sciences of the United States of America. 2008;105(35):13015-13020.
  12

• 6.

  2008

  Hendrik W. Van Deventer; Ping Wu Qing; Daniel T. Bergstralh; Beckley K. Davis; Brian P. O'Connor; Jenny P.-Y. Ting; Jonathan S. Serody

  C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9

  American Journal of Pathology. 2008;173(1):253-264.
  31

• 7.

  2008

  Heather A. Iocca; Sheila R. Plant; Ying Wang; Laura Runkel; Brian P. O'Connor; Emma T. Lundsmith; Kyungmin Hahm; Hendrik W. van Deventer; Linda C. Burkly; et al.

  TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model

  Journal of Neuroimmunology. 2008;194(1-2):97-106.
  12

• 8.

  2007

  Chris B. Moore; Miguel A. Medina; Hendrik W. Van Deventer; Brian P. O'Connor; Scott Cameron; Debra J. Taxman; Robert Maile; Jenny P.-Y. Ting; Bruce A. Cairns

  Downregulation of immune signaling genes in patients with large surface burn injury

  Journal of Burn Care and Research. 2007;28(6):879-887.
  1

• 9.

  2006

  So-Young Eun; Brian P. O'Connor; Athena W. Wong; Hendrick W. Van Deventer; Debra J. Taxman; William Reed; Ping Li; Janice S. Blum; Karen P. McKinnon; Jenny P.-Y. Ting

  Cutting edge: Rho activation and actin polarization are dependent on plexin-A1 in dendritic cells

  Journal of Immunology. 2006;177(7):4271-4275.
  18

• 10.

  2005

  Hendrik W. Van Deventer; William O'Connor Jr.; W. June Brickey; Robert M. Aris; Jenny P.Y. Ting; Jonathan S. Serody

  C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis

  Cancer Research. 2005;65(8):3374-3379.
  22

• 11.

  2005

  Robert Z. Orlowski; Peter M. Voorhees; Reynaldo A. Garcia; Melissa D. Hall; Fred J. Kudrik; Tammy Allred; Anandhi R. Johri; Paul E. Jones; Anastasia Ivanova; Hendrik W. Van Deventer; et al.

  Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

  Blood. 2005;105(8):3058-3065.
  229

• 12.

  2004

  E. Claire Dees; Karen P. McKinnon; Jennifer J. Kuhns; Kathryn A. Chwastiak; Scotty Sparks; Mary Myers; Edward J. Collins; Jeffrey A. Frelinger; Henrik Van Deventer; Frances Collichio; et al.

  Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

  Cancer Immunology, Immunotherapy. 2004;53(9):777-785.
  25

• 13.

  2003

  Athena W. Wong; W. June Brickey; Debra J. Taxman; Hendrick W. van Deventer; William Reed; Jian Xin Gao; Pan Zheng; Yang Liu; Ping Li; Janice S. Blum; et al.

  CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions

  Nature Immunology. 2003;4(9):891-898.
  95

• 14.

  2003

  Cherie H. Dunphy; Hendrik W. Van Deventer; Kathryn J. Carder; Kathleen W. Rao; Georgette A. Dent

  Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13): A Burkitt variant?

  Archives of Pathology and Laboratory Medicine. 2003;127(5):610-613.
  18

• 15.

  2003

  Judith Ng-Cashin; Jennifer J. Kuhns; Susan E. Burkett; John D. Powderly; Robin R. Craven; Hank W. Van Deventer; Suzanne L. Kirby; Jonathan S. Serody

  Host absence of CCR5 potentiates dendritic cell vaccination

  Journal of Immunology. 2003;170(8):4201-4208.
  15

• 16.

  2002

  Hendrik W. Van Deventer; Melissa D. Hall; Robert Z. Orlowski; Beverly S. Mitchell; Lee R. Berkowitz; Cathe Hogan; Cherie H. Dunphy; Julie Koehler; Thomas C. Shea

  Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia

  American Journal of Hematology. 2002;71(3):184-190.
  5

• 17.

  2002

  Hendrik W. Van Deventer; Jonathon S. Serody; Karen P. McKinnon; Casey Clements; W. June Brickey; Jenny P.-Y. Ting

  Transfection of macrophage inflammatory protein 1α into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors

  Journal of Immunology. 2002;169(3):1634-1639.
  31

• 18.

  2001

  E.C. Dees; K. McKinnon; M. Myers; S.D. Sparks; K. Chwastiak; F. Collichio; H. VanDeventer; L.A. Carey; M.E. Brecher; M. Graham; et al.

  Phase I clinical trial of HER2 peptide-pulsed autologous dendritic cells in patients with metastatic breast cancer (MBC)

  Breast Cancer Research and Treatment. 2001;69(3):311.
  1

• 19.

  2001

  Hendrik W. Van Deventer; Jenny P.-Y. Ting

  Nitric oxide inhibits major histocompatibility complex class ii expression on murine dendritic cells

  Blood. 2001;96(11 PART II):46b.
  0

• 20.

  1999

  H. Van Deventer; S. Bernard

  Use of gabapentin to treat taxane-induced myalgias [2]

  Journal of Clinical Oncology. 1999;17(1):434-435.
  25